Screening for Hematology Branch Protocols | MicrobiomeTrials← Back to trialsNCT00001620
Screening for Hematology Branch Protocols
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Enrollment target: 10,000 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
AL Amyloidosis
The purpose of this study is assess safety, safest dose, and effectiveness of venetoclax in combination with dexamethaso…
Birmingham, United StatesEst. completion Sep 2027
Immune Thrombocytopenic PurpuraAutoimmune ThrombocytopeniaThrombopenia
This study aims to determine the hemato-immunological parameters predictive of the evolution of a Immune thrombocytopeni…
Bordeaux, FranceCompleted Mar 5, 2014
Background:
\- The immune system helps the body fight infection and disease. People with immune system problems can get…
Bethesda, United StatesEst. completion Aug 30, 2026